Jane Yee, MD, answers our questions about the prevention of COVID-19 among patients with HIV, the risks these patients may face if they are exposed to the novel coronavirus, and the importance of ensuring...
Findings from a new study highlight the gaps in the UNAIDS 90-90-90 targets that are not being bridged. Lead author James Stannah, MPH, answers our questions about his study and how the target can be...
The IDSA, HIVMA, and AAHIVM have released a policy paper raising awareness about the implementation of inpatient antiretroviral stewardship programs. In this Q&A, paper coauthor David Koren, PharmD,...
A new study evaluated the accuracy of a LAM-based point-of-care test for diagnosing tuberculosis in patients with HIV. Lead author Claudia Denkinger, MD, PhD, answered our questions.
In a session at IAS 2019, Ya-Chi Ho, MD, PhD, MMS, spoke about one of the neglected aspects of HIV treatment. In this Q&A, she answers our questions about this important topic.
Charles Flexner, MD, from Johns Hopkins University answers our questions about aging in HIV, long-acting antiretroviral therapy, and at-risk populations.
Do comorbidities and polypharmacy lead to virologic failure in all populations living with HIV? This was the focus of recent research presented at IDWeek 2018.
Dr Karin Nielsen from UCLA Mattel Children’s Hospital answers our questions about HIV in infants, mother-to-child transmission, and the future of HIV treatment.
A new study evaluated the association between integrase strand transfer inhibitors with hepatic steatosis, which has been associated with increased ASCVD risk in the general population. Lead researcher...
